KOD
Kodiak Sciences Inc.
A clinical-stage biotech developing next-generation medicines for retinal diseases that cause blindness, aiming for longer-lasting anti-VEGF eye injections with candidates like Zenkuda (tarcocimab tedromer) and the bispecific KSI-501. Founded in 2009 as Oligasis and renamed Kodiak Sciences in 2015, the company takes its name from Alaska's mighty Kodiak bear — and fittingly, its Swiss manufacturing plant is called "Ursus," the Latin word for bear.
CUSIP: 50015M109HealthcareUS1 holder
Total Value
$1.38M
Total Shares
35.5K
Net Share Change
-5.9K
Activity
1 selling
Investor
Value
Shares
Weight
Change
